Myriad Genetics (MYGN) EBIT (QoQ) (2009 - 2026)
Myriad Genetics (MYGN) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 294.69 Mn | 170.29 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -438.60% |
| Dec 31, 2025 | 75.54% |
| Sep 30, 2025 | 92.92% |
| Jun 30, 2025 | -1,035.17% |
| Mar 31, 2025 | 25.64% |
| Dec 31, 2024 | -95.00% |
| Sep 30, 2024 | 45.21% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | 11.15% |
| Dec 31, 2023 | 47.75% |
| Sep 30, 2023 | 47.14% |
| Jun 30, 2023 | -117.82% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -16.00% |
| Sep 30, 2022 | -152.81% |
| Jun 30, 2022 | 30.47% |
| Mar 31, 2022 | 40.60% |
| Dec 31, 2021 | 46.06% |
| Sep 30, 2021 | -284.13% |
| Jun 30, 2021 | 55.46% |